Eliot Engel actually said...

U.S. prescription drug spending rose by 41 percent between 2007 and 2017.

The shroud of secrecy that veils the drug supply chain can make it challenging even for experienced health care professionals.

Due to the lack of transparency, my constituents often get a pricing surprise when they arrive at their pharmacy.

Mr. McCaul and I recently reintroduced the Global Fragility Act to promote this approach.